Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 8/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.42 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.42 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.41 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7516040 | 1.00 | P2RY12 (0.44) | P2RY12LMNAP2RY2P2RY1P2RY6 | |
| SCHEMBL6471947 | 0.90 | ADORA1 (0.44) | — | |
| SCHEMBL21063251 | 0.90 | ADORA1 (0.44) | — | |
| SCHEMBL29551585 | 0.90 | ADORA1 (0.44) | — | |
| SCHEMBL6471942 | 0.90 | ADORA1 (0.44) | — | |
| SCHEMBL19771221 | 0.89 | P2RY12 (0.43) | P2RY12P2RY2P2RY1P2RY6PRMT6 | |
| SCHEMBL19767623 | 0.89 | P2RY12 (0.43) | P2RY12P2RY2P2RY1P2RY6PRMT6 | |
| SCHEMBL17283109 | 0.89 | P2RY12 (0.43) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL19519464 | 0.89 | P2RY12 (0.43) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL7521379 | 0.88 | P2RX3 (0.49) | P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882059-A1 | SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDE N3-'P5'- PHOSPHORAMIDATES | LYNX THERAPEUTICS, INC. (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997031009-A1 | SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDE N3'→P5' PHOSPHORAMIDATES | LYNX THERAPEUTICS, INC. (US) | 1997-08-28 | — | — | WO | disclosed |